SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung nodules seen in a high percentage of non-smokers

2.

An ultrasound breast patch with conformability might help with early breast cancer detection.

3.

Is Exercise an Effective Treatment for Prostate Cancer?

4.

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

5.

Adopted cancer cells and the effects of their presence.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot